For: | Leowattana W, Leowattana P, Leowattana T. Systemic treatments for resectable carcinoma of the esophagus. World J Gastroenterol 2023; 29(30): 4628-4641 [PMID: 37662861 DOI: 10.3748/wjg.v29.i30.4628] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i30/4628.htm |
Number | Citing Articles |
1 |
Jin Li, Zhenqin Luo, Siqing Jiang, Junjun Li. Advancements in neoadjuvant immune checkpoint inhibitor therapy for locally advanced head and neck squamous Carcinoma: A narrative review. International Immunopharmacology 2024; 134: 112200 doi: 10.1016/j.intimp.2024.112200
|
2 |
Zhong Wu, Zongxin Zhang, Chao Gu. Prognostic and clinicopathological impact of systemic inflammation response index (SIRI) on patients with esophageal cancer: a meta-analysis. Systematic Reviews 2025; 14(1) doi: 10.1186/s13643-025-02847-7
|
3 |
Xinting Li, Xinran Zhao, Xingxing Su, Jie Wen, Shuya Yang, Yi Qin, Shuxin Yan, Yijian Yao, Xiaozhong Li, Xiaoxia Wang. IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells. Archives of Biochemistry and Biophysics 2024; 758: 110064 doi: 10.1016/j.abb.2024.110064
|
4 |
Zhiyuan Yao, Ge Wei, Peng Song, Changlei Li, Guohua Wang, Zengjin Wen, Lisai Liu, Guangqi Li. Trop2, Nectin-4, and PD-L1 expression profiles in esophageal squamous cell carcinoma: Implications for combined immunotherapy and ADC targeted therapies. Pathology - Research and Practice 2025; 271: 156032 doi: 10.1016/j.prp.2025.156032
|
5 |
Haowen Zhang, Tao Jin, Yuhao Peng, Siyuan Luan, Xiaokun Li, Xin Xiao, Yong Yuan. Association between plasma circulating tumor DNA and the prognosis of esophageal cancer patients: a meta-analysis. International Journal of Surgery 2024; 110(7): 4370 doi: 10.1097/JS9.0000000000001373
|
6 |
Huiping Chen, Jingqun Tang, Juanjuan Xiang. Alternative Splicing in Tumorigenesis and Cancer Therapy. Biomolecules 2025; 15(6): 789 doi: 10.3390/biom15060789
|